Skip to main content
Pathway Medicine

Search form

GoozyGooz

Become an Author
Recommended Reading
About this Resource

You are here

Home » Pharmacology » Antibacterials » Bacterial Ribosome Inhibitors

Book navigation

  • Immunology
  • Microbiology
  • Cardiovascular Medicine
  • Respiratory Medicine
  • Renal Medicine
  • Gastrointestinal Medicine
  • Hepatology
  • Endocrinology
  • Hematology and Oncology
  • Dermatology
  • Musculoskeletal System
  • Pharmacology
    • Basic Pharamacology
    • Antibacterials
      • Bacterial Cell Wall Synthesis Inhibitors
      • Bacterial Ribosome Inhibitors
        • Tetracyclins
        • Aminoglycosides
        • Macrolides
        • Chloramphenicol
        • Clindamycin
        • Linezolid
      • Bacterial Gyrase Inhibitors (Fluoroquinolones)
      • Bacterial Metabolism Inhibitors
      • Tuberculosis Chemotherapeutics
      • Leprosy Chemotherapeutics
    • Antivirals
    • Antifungals
    • Antiprotozoals
    • Blood Pharmacology
    • Diuretics
    • GI Pharmacology
  • Basic Concepts
  • Genetic Disorders
  • Surgery
  • Neurology

Linezolid

Overview
  • Linezolid is a novel synthetic antibacterial which is highly effective for gram positive bacteria that are highly resistant to other antibiotics. It's mechanism of action is through inhibition of the 50S subunit of the bacterial ribosome. It is often used in patients with serious Methicillin-resistant S. aureus (MRSA) infections who cannot tolerate vancomycin.
‹ Clindamycin up Bacterial Gyrase Inhibitors (Fluoroquinolones) ›
Copyright 2010-2017 by Pathway Medicine
Terms of Use